Results 241 to 247 of about 36,243,680 (247)

Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan

Modern Rheumatology, 2017
Takao Fujii, Tsuneyo Mimori, Naoto Tamura   +2 more
exaly  

Post-marketing dosing changes in the label of biologicals

British Journal of Clinical Pharmacology, 2019
Helga Gardarsdottir, Lotte A Minnema
exaly  

Safety and effectiveness of istradefylline in patients with Parkinson’s disease: interim analysis of a post-marketing surveillance study in Japan

Expert Opinion on Pharmacotherapy, 2018
Akihisa Mori, Makio Takahashi
exaly  

Zolpidem in Insomnia: A 3-Year Post-Marketing Surveillance Study in Switzerland

Journal of International Medical Research, 1995
exaly  

1．The Survey of Trends on Japanese Post-marketing Study after Enforcement of Revised Good Post-marketing Study Practice （GPSP)

Japanese Journal of Pharmacoepidemiology/Yakuzai Ekigaku, 2020
exaly  

Post-marketing surveillance of sertindole

International Journal of Psychiatry in Clinical Practice, 2002
exaly  

Patient and Physician Satisfaction with Rofecoxib in Osteoarthritis: Results of a Post-marketing Surveillance Study in Primary Care in Germany

Current Medical Research and Opinion, 2002
exaly